10+
installs · ≈30
—
0 ratings
2025-03-14
first release
2025-03-14
last update
Description
This app is specifically intended for participants in the GSK 221458 study only
This app is specifically intended for participants in the GSK 221458 study only.
It contains Televisit functionality and allows participants to complete questionnaires.
The study is a Phase 1, first-time-in-human, three-part study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity of GSK4527363 in healthy participants (Part A), participants with active systemic lupus erythematosus (Part B), and healthy participants of Chinese and Japanese descent (Part C).
(Televisit tasks are not enabled by default and may be enabled as needed, by study officials.)
What's new
Initial release
Details
| Version | 5.4.800.15-prod |
|---|---|
| Minimum Android version | 8.0 |
| Reviews | 0 |
| Available in | Argentina, American Samoa, Bulgaria, Brazil, Canada, Spain, United Kingdom, Guam, Marshall Islands, Northern Mariana Islands, Poland, Puerto Rico and 4 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-14 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.gsk221458"
